ID
43573
Descrição
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome for internal use, not to be databased
Palavras-chave
Versões (3)
- 12/09/2017 12/09/2017 -
- 12/09/2017 12/09/2017 -
- 20/09/2021 20/09/2021 -
Transferido a
20 de setembro de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
visit period 1,2,3 & 4 baseline/adverse event checklist PK and tolerability of ropinirole as 5 new formulations 101468/197
visit period 1,2,3 & 4 baseline/adverse event checklist PK and tolerability of ropinirole as 5 new formulations 101468/197
Similar models
visit period 1,2,3 & 4 baseline/adverse event checklist PK and tolerability of ropinirole as 5 new formulations 101468/197
C3174092 (UMLS CUI [1,2])